Pharmaceutical Executive-12-01-2012

Issue PDF
Pharmaceutical Executive

December 01, 2012

The Puzzle Master

Pharmaceutical Executive
Column

December 01, 2012

Tax and budget decisions will shape the healthcare market and drug research and regulation.

Pharmaceutical Executive
From the Editor

December 01, 2012

The calendar says its wrap-up time, not just for gifts but for some of the trends that shaped the industry-for good or bad-in 2012.

Pharmaceutical Executive
Features

December 01, 2012

At two years and counting, what's the secret of success in negotiating pricing under the new AMNOG legislation?

Pharmaceutical Executive

Eli Lilly's pioneering pact with leading CRO Covance made big news when it happened. Four years later, both parties can point to metrics that suggest the benefit is mutual.

Pharmaceutical Executive
Features

December 01, 2012

Europe's chief regulator charts a strategy from many moving parts. Dr Guido Rasi talks to Pharm Exec's William Looney.

Pharmaceutical Executive
Column

December 01, 2012

Ben Comer profiles 10 innovative technologies designated as new and revolutionary tools for the treatment of disease and disability.

Pharmaceutical Executive
Column

December 01, 2012

How to stop worrying and learn to love the data.